Stempoint Capital »

Vanda Pharmaceuticals shares owned by Stempoint Capital

Quarter-by-quarter ownership of Vanda Pharmaceuticals (VNDA) shares owned by Stempoint Capital from 13F filings

Historical chart of Stempoint Capital investment in Vanda Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Vanda Pharmaceuticals held by Stempoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vanda Pharmaceuticals by Stempoint Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $520k 59k 8.82

More positions owned by Stempoint Capital

Abivax Sa Sponsored Ads (ABVX)
Scholar Rock Hldg Corp (SRRK)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Syndax Pharmaceuticals (SNDX)
Structure Therapeutics Sponsored Ads (GPCR)
Arcellx Common Stock (ACLX)
Roivant Sciences SHS (ROIV)
Terns Pharmaceuticals (TERN)
Twist Bioscience Corp (TWST)
Immunovant (IMVT)
Dyne Therapeutics (DYN)
Xenon Pharmaceuticals (XENE)
Surrozen Com New (SRZN)
Celcuity (CELC)
Mineralys Therapeutics (MLYS)

View all positions for Stempoint Capital

Top funds holding Vanda Pharmaceuticals

BlackRock
Vanguard Group
Millennium Management
Renaissance Technologies
Acadian Asset Management
Dimensional Fund Advisors
AIGH Capital Management
Geode Capital Management
State Street Corporation
Krensavage Asset Management
Empire Financial Management Company
Two Sigma Advisers
Connor, Clark & Lunn Investment Management
Jacobs Levy Equity Management
AQR Capital Management

View all funds holding Vanda Pharmaceuticals